{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:32:22Z","timestamp":1793694742841,"version":"4.5.1"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011025","name":"Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016056","name":"Minderoo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.mam.2025.101423","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T07:50:57Z","timestamp":1766044257000},"page":"101423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-1449","authenticated-orcid":false,"given":"Michaela T.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Hyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Torode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telma","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diep Thi Ngoc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Balshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Auste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Ling","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vallely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Molano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchia","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Whop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Bateson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate T.","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2025.101423_bib1","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/S1470-2045(12)70532-6","article-title":"Status of radiotherapy resources in Africa: an international atomic energy agency analysis","volume":"14","author":"Abdel-Wahab","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1470-2045(23)00619-8","article-title":"Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis","volume":"25","author":"Abu Awwad","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12904-020-00558-5","article-title":"Challenges on the provision of palliative care for patients with cancer in low- and middle-income countries: a systematic review of reviews","volume":"19","author":"Abu-Odah","year":"2020","journal-title":"BMC Palliat. Care"},{"key":"10.1016\/j.mam.2025.101423_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","article-title":"Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study","volume":"17","author":"Aitken","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.mam.2025.101423_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111912","article-title":"Prophylactic human papillomavirus vaccination: from the origin to the current state","volume":"10","author":"Akhatova","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.mam.2025.101423_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2021.06.027","article-title":"Risk factors analysis of persistence, progression and recurrence in vaginal intraepithelial neoplasia","volume":"162","author":"Ao","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib7","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.mam.2025.101423_bib8","first-page":"CD009069","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2025.101423_bib9","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.mam.2025.101423_bib10","first-page":"1083","article-title":"2020 list of human papillomavirus assays suitable for primary cervical cancer screening","volume":"27","author":"Arbyn","year":"2021","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","article-title":"Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis","volume":"23","author":"Arbyn","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/IDOG\/2006\/40470","article-title":"Epidemiology and natural history of human papillomavirus infections in the female genital tract","author":"Ault","year":"2006","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.mam.2025.101423_bib13","series-title":"National Strategy for the Elimination of Cervical Cancer in Australia","year":"2023"},{"key":"10.1016\/j.mam.2025.101423_bib14","series-title":"National Strategy for the Elimination of Cervical Cancer in Australia","year":"2023"},{"key":"10.1016\/j.mam.2025.101423_bib15","series-title":"National Cervical Screening Program Monitoring Report 2022 (No. Catalogue Number CAN 149.), Catalogue Number CAN 149","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib16","series-title":"GARDASIL Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine 20,40,40,20 micrograms\/0.5mL Sterile Liquid Syringe (124410) [Online]","year":"2006"},{"key":"10.1016\/j.mam.2025.101423_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2229-516X.179027","article-title":"Human papillomavirus-associated cancers: a growing global problem","volume":"6","author":"Bansal","year":"2016","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.mam.2025.101423_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100056","article-title":"Efficacy of single-dose HPV vaccination among young African women","volume":"1","author":"Barnabas","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.mam.2025.101423_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib20","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib21","first-page":"djaf054","article-title":"Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the human papillomavirus\u2013automated visual evaluation consortium","author":"Befano","year":"2025","journal-title":"JNCI J. Natl. Cancer Inst"},{"key":"10.1016\/j.mam.2025.101423_bib22","article-title":"National cervical screening program renewal: effectiveness modelling and economic evaluation in the Australian setting (assessment report)","author":"Bin Lew","year":"2013","journal-title":"MSAC Appl. No."},{"key":"10.1016\/j.mam.2025.101423_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group","volume":"87","author":"Bosch","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mam.2025.101423_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jnci\/88.15.1060","article-title":"Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain","volume":"88","author":"Bosch","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mam.2025.101423_bib25","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","article-title":"The IARC perspective on cervical cancer screening","volume":"385","author":"Bouvard","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101423_bib26","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2013.06.064","article-title":"Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study","volume":"31","author":"Brisson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib28","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2025.101423_bib29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/ijc.30871","article-title":"Looking beyond human papillomavirus (HPV) genotype 16 and 18: defining HPV genotype distribution in cervical cancers in Australia prior to vaccination","volume":"141","author":"Brotherton","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib30","series-title":"2024 Cervical Cancer Elimination Progress Report: Australia's Progress Towards the Elimination of Cervical Cancer as a Public Health Problem","author":"Brotherton","year":"2025"},{"key":"10.1016\/j.mam.2025.101423_bib31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.mam.2025.101423_bib33","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.mam.2025.101423_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089974","article-title":"Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys","volume":"9","author":"Burger","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101423_bib35","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1016\/j.vaccine.2018.04.061","article-title":"Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country","volume":"36","author":"Burger","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib36","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S2468-2667(20)30006-2","article-title":"Projected time to elimination of cervical cancer in the USA: a comparative modelling study","volume":"5","author":"Burger","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.mam.2025.101423_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/aje\/kwu159","article-title":"An updated natural history model of cervical cancer: derivation of model parameters","volume":"180","author":"Campos","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.mam.2025.101423_bib39","series-title":"An Australian Success Story: the HPV Vaccine [Online]","author":"Canfell","year":"2017"},{"key":"10.1016\/j.mam.2025.101423_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13697137.2018.1428296","article-title":"Cervical screening in HPV-vaccinated populations","volume":"21","author":"Canfell","year":"2018","journal-title":"Climacteric J. Int. Menopause Soc."},{"key":"10.1016\/j.mam.2025.101423_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","article-title":"Chapter 3: cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking","author":"Castellsague","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.mam.2025.101423_bib43","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JGO.2016.003954","article-title":"Management and care of women with invasive cervical cancer: American society of clinical oncology resource-stratified clinical practice guideline","volume":"2","author":"Chuang","year":"2016","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer JID - 0370635"},{"key":"10.1016\/j.mam.2025.101423_bib47","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101423_bib48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jpainsymman.2020.09.036","article-title":"Estimating the number of patients receiving specialized palliative care globally in 2017","volume":"61","author":"Connor","year":"2021","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.mam.2025.101423_bib49","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1111\/jocn.12947","article-title":"Barriers to cervical cancer screening experienced by Lesbian women: a qualitative study","volume":"25","author":"Curmi","year":"2016","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.mam.2025.101423_bib50","series-title":"Regional Variation in Cervical Cancer Screening Participation & Outcomes Among Aboriginal and Non-aboriginal Australian Women: New South Wales (2006-2013)","author":"Dasgupta","year":"2018"},{"key":"10.1016\/j.mam.2025.101423_bib51","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib53","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib54","article-title":"Reduced number of doses for HPV vaccination series: Work group progress and literature update","author":"de Sisto","year":"2025","journal-title":"Natl. Canter Immun. Respir. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.mam.2025.101423_bib56","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1001\/jama.294.17.2173","article-title":"Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial","volume":"294","author":"Denny","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mam.2025.101423_bib57","series-title":"Victorian Population Health Survey of People with an Intellectual Disability 2013","year":"2015"},{"key":"10.1016\/j.mam.2025.101423_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040645","article-title":"Factors associated with advanced stage at diagnosis of cervical cancer in addis ababa, Ethiopia: a population-based study","volume":"10","author":"Dereje","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.mam.2025.101423_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.mam.2025.101423_bib60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ucl.2016.06.003","article-title":"The role of human papilloma virus in penile carcinogenesis and preneoplastic lesions: a potential target for vaccination and treatment strategies","volume":"43","author":"Diorio","year":"2016","journal-title":"Urol. Clin. North Am"},{"key":"10.1016\/j.mam.2025.101423_bib61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2025.101423_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.mam.2025.101423_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100836","article-title":"Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis","volume":"34","author":"Dorji","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.mam.2025.101423_bib64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib65","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1470-2045(15)00287-9","article-title":"Expanding global access to radiotherapy: the IAEA perspective","volume":"16","author":"Enwerem-Bromson","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib66","article-title":"Cervical cancer elimination planning tool","author":"Ervik","year":"2025","journal-title":"Cerv. Cancer Elimin. Lyon Fr. Int. Agency Res. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib67","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.mam.2025.101423_bib68","series-title":"Global Cancer Observatory: Cancer Today [Online], Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2020"},{"key":"10.1016\/j.mam.2025.101423_bib69","article-title":"CERVIX UTERI fact sheet","author":"Ferlay","year":"2024","journal-title":"Glob. Cancer Obs. Cancer Today"},{"key":"10.1016\/j.mam.2025.101423_bib70","article-title":"CERVIX UTERI fact sheet","author":"Ferlay","year":"2025","journal-title":"Age-Stand. Rate World 100 000 Mortal. Females 2022"},{"key":"10.1016\/j.mam.2025.101423_bib71","article-title":"Performance of alternative strategies for primary cervical cancer screening in Sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies","volume":"351","author":"Fokom-Domgue","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.mam.2025.101423_bib72","series-title":"The Cervix","first-page":"317","article-title":"The pathology of glandular cervical lesions","author":"Ganesan","year":"2006"},{"key":"10.1016\/j.mam.2025.101423_bib73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2020.100195","article-title":"IPVS statement on \u201cTemporary HPV vaccine shortage: implications globally to achieve equity\u201d","author":"Garland","year":"2020","journal-title":"Papillomavirus Res. Amst. Neth"},{"key":"10.1016\/j.mam.2025.101423_bib75","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jcpo.2013.07.002","article-title":"Breast and cervical cancer control in low and middle-income countries: human rights meet sound health policy","volume":"1","author":"Ginsburg","year":"2013","journal-title":"J. Cancer Policy"},{"issue":"Suppl. 10","key":"10.1016\/j.mam.2025.101423_bib76","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"Giuliano","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2025.101423_bib78","article-title":"Data visualization tools for exploring the global cancer burden in 2022","year":"2022","journal-title":"Int. Agency for Res. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib79","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12160-017-9876-2","article-title":"Cancer care coordination: a systematic review and meta-analysis of over 30 years of empirical studies","volume":"51","author":"Gorin","year":"2017","journal-title":"Ann. Behav. Med. Publ. Soc. Behav. Med."},{"key":"10.1016\/j.mam.2025.101423_bib80","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/s41591-022-02109-2","article-title":"Global and regional estimates of orphans attributed to maternal cancer mortality in 2020","volume":"28","author":"Guida","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101423_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185332","article-title":"Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017\u20132035: example from Australia","volume":"13","author":"Hall","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101423_bib82","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.mam.2025.101423_bib83","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/s41591-023-02601-3","article-title":"Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV","volume":"29","author":"Hall","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101423_bib84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","article-title":"Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review","volume":"16","author":"Harder","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.mam.2025.101423_bib85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1470-2045(22)00002-X","article-title":"Japan resumes active recommendations of HPV vaccine after 8\u00b75 years of suspension","volume":"23","author":"Haruyama","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib86","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101423_bib87","article-title":"Review of long-term immunogenicity following HPV vaccination: gaps in current knowledge","volume":"18","author":"Hoes","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.mam.2025.101423_bib88","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12961-015-0031-x","article-title":"The strategic case for establishing public-private partnerships in cancer care","volume":"13","author":"Holden","year":"2015","journal-title":"Health Res. Pol. Syst."},{"key":"10.1016\/j.mam.2025.101423_bib89","article-title":"Cancer in Low- and middle-income countries: an economic overview","volume":"vol. 3","author":"Horton","year":"2015"},{"key":"10.1016\/j.mam.2025.101423_bib90","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1186\/s12913-022-08800-x","article-title":"Social return on investment economic evaluation of supportive care for lung cancer patients in acute care settings in Australia","volume":"22","author":"Hyatt","year":"2022","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.mam.2025.101423_bib91","article-title":"Strengthening cancer control in the South Pacific through coalition-building: a co-design framework","volume":"33","author":"Hyatt","year":"2023","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.mam.2025.101423_bib93","series-title":"Cervical Cancer Screening. IARC Handbook Cancer Prevention","author":"International Agency for Research on Cancer","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib95","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/curroncol28020117","article-title":"The out-of-pocket cost burden of cancer Care-A systematic literature review","volume":"28","author":"Iragorri","year":"2021","journal-title":"Curr. Oncol. Tor. Ont"},{"key":"10.1016\/j.mam.2025.101423_bib96","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-Valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101423_bib97","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/ijc.33759","article-title":"The road to cervical cancer elimination in Malaysia: evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support","volume":"149","author":"Keane","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101645","article-title":"Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+\/CIN3+) among women living with HIV: a systematic review and meta-analysis","volume":"53","author":"Kelly","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.mam.2025.101423_bib99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/NCC.0000000000000890","article-title":"Improving cervical screening in trans and gender-diverse people","volume":"45","author":"Kerr","year":"2022","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.mam.2025.101423_bib37","first-page":"1","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"Kitchener","year":"2014","journal-title":"Health Technol. Assess. Winch. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib100","first-page":"101","article-title":"High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)","volume":"10","author":"Kjaer","year":"2001","journal-title":"Cancer Epidemiol Biomark. Prev JID - 9200608"},{"key":"10.1016\/j.mam.2025.101423_bib101","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2025.101423_bib102","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1200\/GO.21.00025","article-title":"Cervical cancer-associated suffering: estimating the palliative care needs of a highly vulnerable population","volume":"7","author":"Krakauer","year":"2021","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib103","series-title":"One-Dose HPV Vaccination Provides Comparable Protection to Two Doses: Findings from the ESCUDDO Trial","author":"Kreimer","year":"2025"},{"key":"10.1016\/j.mam.2025.101423_bib104","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(13)60809-0","article-title":"Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study","volume":"382","author":"Kreimer","year":"2013","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib105","first-page":"14","article-title":"Refocusing cancer supportive care: a framework for integrated cancer care","volume":"31","author":"Krishnasamy","year":"2022","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib107","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101423_bib108","series-title":"Private Lives 2: the Second National Survey on the Health and Wellbeing of GLBT Australians (Report)","author":"Leonard","year":"2012"},{"key":"10.1016\/j.mam.2025.101423_bib109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-9276-12-18","article-title":"Patient-centred access to health care: conceptualising access at the interface of health systems and populations","volume":"12","author":"Levesque","year":"2013","journal-title":"Int. J. Equity Health"},{"key":"10.1016\/j.mam.2025.101423_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151619","article-title":"Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand","volume":"11","author":"Lew","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101423_bib111","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.mam.2025.101423_bib112","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1470-2045(23)00066-9","article-title":"Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib114","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jech-2020-216305","article-title":"Cost-effectiveness of extending the HPV vaccination to boys: a systematic review","volume":"75","author":"Linertov\u00e1","year":"2021","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.mam.2025.101423_bib115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib116","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clindermatol.2013.08.007","article-title":"HPV-associated diseases","volume":"32","author":"Ljubojevic","year":"2014","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.mam.2025.101423_bib117","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2005.10.021","article-title":"Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic oncology group study","volume":"23","author":"Long","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib118","first-page":"1710","article-title":"Warts (non-genital)","volume":"2014","author":"Loo","year":"2014","journal-title":"BMJ Clin. Evid."},{"key":"10.1016\/j.mam.2025.101423_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25110","article-title":"Evidence of synergistic relationships between HIV and human papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status","volume":"21","author":"Looker","year":"2018","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.mam.2025.101423_bib120","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/infdis\/jiaa621","article-title":"Human papillomavirus vaccines","volume":"224","author":"Markowitz","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib121","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jfprhc-2014-101082","article-title":"Barriers to cervical cancer screening among ethnic minority women: a qualitative study","volume":"41","author":"Marlow","year":"2015","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"key":"10.1016\/j.mam.2025.101423_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001318.pub2","article-title":"Surgery for cervical intraepithelial neoplasia","author":"Martin-Hirsch","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2025.101423_bib123","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib124","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2613.2001.00177.x","article-title":"Biology of human papillomaviruses","volume":"82","author":"Mcmurray","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.mam.2025.101423_bib125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(16)00344-5","article-title":"Managing the public-private mix to achieve universal health coverage","volume":"388","author":"McPake","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102385","article-title":"Integration of immunotherapy into treatment of cervical cancer: recent data and ongoing trials","volume":"106","author":"Monk","year":"2022","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mam.2025.101423_bib127","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12916-024-03701-8","article-title":"Breaking barriers: why including boys and men is key to HPV prevention","volume":"22","author":"Naidoo","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.mam.2025.101423_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007380","article-title":"Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea","volume":"7","author":"Nguyen","year":"2022","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.mam.2025.101423_bib129","series-title":"An Investment Case Study on HPV Vaccination in Viet Nam","author":"Nguyen","year":"2023"},{"key":"10.1016\/j.mam.2025.101423_bib130","series-title":"Cervical Cancer Elimination Progress Report: Australia's Progress Towards the Elimination of Cervical Cancer as a Public Health Problem","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.mam.2025.101423_bib132","series-title":"Plan of Action for Cervical Cancer Prevention and Control 2018-2030","year":"2019"},{"key":"10.1016\/j.mam.2025.101423_bib133","series-title":"Diagnosis of Uterine Cancer by the Vaginal Smear","volume":"vol. 46","author":"Papanicolaou","year":"1943"},{"key":"10.1016\/j.mam.2025.101423_bib134","first-page":"211","article-title":"The diagnostic value of vaginal smears in carcinoma of the uterus. 1941","volume":"121","author":"Papanicolaou","year":"1997","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.mam.2025.101423_bib135","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull."},{"key":"10.1016\/j.mam.2025.101423_bib136","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12914-020-00237-9","article-title":"Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women","volume":"20","author":"Perehudoff","year":"2020","journal-title":"BMC Int. Health Hum. Right"},{"key":"10.1016\/j.mam.2025.101423_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105671","article-title":"2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)","volume":"172","author":"Poljak","year":"2024","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.mam.2025.101423_bib138","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the Costa Rica vaccine trial","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib139","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciaa166","article-title":"The natural history of anal high-grade squamous intraepithelial lesions in gay and bisexual men","volume":"72","author":"Poynten","year":"2021","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.mam.2025.101423_bib141","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1016\/j.vaccine.2022.08.020","article-title":"Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World health organization consultations, October 2021-March 2022","volume":"40","author":"Prudden","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib142","article-title":"Lower cost strategies for triage of human papillomavirus DNA-positive women","author":"Qiao","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib143","series-title":"Cancer Care in Public and Private Hospitals 2005-2014","article-title":"Queensland cancer quality index: indicators of safe, quality cancer care","year":"2017"},{"key":"10.1016\/j.mam.2025.101423_bib144","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1470-2045(19)30308-0","article-title":"Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact","volume":"20","author":"Rodin","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib145","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1016\/S1470-2045(18)30681-8","article-title":"National cancer control plans: a global analysis","volume":"19","author":"Romero","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib146","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2025.101423_bib147","first-page":"13","article-title":"Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule on immunogenicity and cervical cancer prevention","author":"Rostami Varnousfaderani","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.mam.2025.101423_bib148","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101423_bib149","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.19095","article-title":"Protection against persistent HPV-16\/18 infection after different number of doses of quadrivalent vaccine in girls and young women: a randomized clinical trial","volume":"8","author":"Sauvageau","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.mam.2025.101423_bib150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijgo.2012.10.014","article-title":"Meta-analysis of the effectiveness of cryotherapy in the treatment of cervical intraepithelial neoplasia","volume":"120","author":"Sauvaget","year":"2013","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.mam.2025.101423_bib151","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","article-title":"Human papillomavirus: epidemiology and public health","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.mam.2025.101423_bib152","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.mam.2025.101423_bib153","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrmicro2872","article-title":"Understanding and learning from the success of prophylactic human papillomavirus vaccines","volume":"10","author":"Schiller","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2025.101423_bib154","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","article-title":"Explanations for the high potency of HPV prophylactic vaccines","volume":"36","author":"Schiller","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib155","series-title":"Colposcopy and Treatment of Cervical Intraepithelial Neoplasia","author":"Sellors","year":"2003"},{"key":"10.1016\/j.mam.2025.101423_bib156","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/ijc.33120","article-title":"Cervical cancer survival in Sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study","volume":"147","author":"Sengayi-Muchengeti","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib157","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.mam.2025.101423_bib158","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju009","article-title":"Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India","author":"Shastri","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mam.2025.101423_bib159","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0140-6736(17)30872-3","article-title":"Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents","volume":"390","author":"Sheehan","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12889-023-15318-2","article-title":"Examining multilevel influences on parental HPV vaccine hesitancy among multiethnic communities in Los Angeles: a qualitative analysis","volume":"23","author":"Shin","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.mam.2025.101423_bib161","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib162","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","article-title":"Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study","volume":"5","author":"Simms","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.mam.2025.101423_bib163","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","article-title":"Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population","volume":"29","author":"Simms","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101423_bib164","doi-asserted-by":"crossref","DOI":"10.5694\/mja16.00289","article-title":"Impact of the Australian National cervical screening program in women of different ages","volume":"205","author":"Smith","year":"2016","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.mam.2025.101423_bib165","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/ijc.23633","article-title":"The predicted impact of vaccination on human papillomavirus infections in Australia","volume":"123","author":"Smith","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib166","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jadohealth.2011.03.010","article-title":"Age-specific prevalence of human papillomavirus infection in males: a global review","volume":"48","author":"Smith","year":"2011","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.mam.2025.101423_bib167","doi-asserted-by":"crossref","first-page":"1941e","DOI":"10.5694\/mja15.00912","article-title":"Impact of HPV sample self-collection for underscreened women in the renewed cervical screening program","volume":"204","author":"Smith","year":"2016","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.mam.2025.101423_bib168","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ijc.33867","article-title":"Potential effectiveness of a therapeutic HPV intervention campaign in Uganda","volume":"150","author":"Spencer","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib169","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.mam.2025.101423_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.34213","article-title":"The intersection of sexual orientation with race and ethnicity in cervical cancer screening","volume":"128","author":"Stenzel","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib171","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1470-2045(15)00223-5","article-title":"Global cancer surgery: delivering safe, affordable, and timely cancer surgery","volume":"16","author":"Sullivan","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib172","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101423_bib173","series-title":"Current Health Expenditure (% of GDP)","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib174","series-title":"Financing for Cervical Cancer Elimination in the Philippines","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib175","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.mam.2025.101423_bib176","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10865-022-00283-9","article-title":"Understanding medical mistrust and HPV vaccine hesitancy among multiethnic parents in Los Angeles","volume":"46","author":"Tsui","year":"2023","journal-title":"J. Behav. Med."},{"key":"10.1016\/j.mam.2025.101423_bib177","series-title":"Gardasil [Online]","year":"2023"},{"key":"10.1016\/j.mam.2025.101423_bib179","series-title":"Consultation Outcomes Summary Report","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib180","doi-asserted-by":"crossref","first-page":"e1336","DOI":"10.1016\/S2214-109X(22)00271-6","article-title":"Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT)","volume":"10","author":"Vallely","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.mam.2025.101423_bib181","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djs395","article-title":"Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis","author":"van de Velde","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mam.2025.101423_bib182","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1002\/cam4.5686","article-title":"Dynamics of oral human papillomavirus infection in healthy population and head and neck cancer","volume":"12","author":"Vani","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.mam.2025.101423_bib183","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1470-2045(20)30316-8","article-title":"The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis","volume":"21","author":"Ward","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib184","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.mam.2025.101423_bib185","doi-asserted-by":"crossref","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mam.2025.101423_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106439","article-title":"Treatment approaches for women with positive cervical screening results in low-and middle-income countries","volume":"144","author":"Wentzensen","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.mam.2025.101423_bib187","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/cncr.29954","article-title":"The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: a retrospective registry cohort study in Queensland, Australia (2000-2011)","volume":"122","author":"Whop","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.mam.2025.101423_bib188","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/ajco.12463","article-title":"Indigenous Australians with non-small cell lung cancer or cervical cancer receive suboptimal treatment","volume":"13","author":"Whop","year":"2017","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.mam.2025.101423_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106314","article-title":"Achieving cervical cancer elimination among Indigenous women","volume":"144","author":"Whop","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.mam.2025.101423_bib190","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.vaccine.2013.06.016","article-title":"Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects","volume":"31","author":"Wigle","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.mam.2025.101423_bib191","series-title":"WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention","year":"2013"},{"key":"10.1016\/j.mam.2025.101423_bib192","series-title":"\u2018Best Buys\u2019 and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases","year":"2017"},{"key":"10.1016\/j.mam.2025.101423_bib193","series-title":"Cervical Cancer Elimination Initiative [Online]","year":"2018"},{"key":"10.1016\/j.mam.2025.101423_bib194","series-title":"WHO Guidelines for the Use of Thermal Ablation for Cervical Pre-cancer Lesions","year":"2019"},{"key":"10.1016\/j.mam.2025.101423_bib195","series-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","year":"2020"},{"key":"10.1016\/j.mam.2025.101423_bib196","series-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","year":"2020"},{"key":"10.1016\/j.mam.2025.101423_bib197","series-title":"WHO Framework for Strengthening and scaling-up Services for the Management of Invasive Cervical Cancer (Technical Document)","year":"2020"},{"key":"10.1016\/j.mam.2025.101423_bib198","series-title":"WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention","year":"2021"},{"key":"10.1016\/j.mam.2025.101423_bib199","series-title":"Human Papillomavirus Vaccines: WHO Position Paper (2022 Update)","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib200","series-title":"Human Papillomavirus (HPV) Vaccination Coverage [Online]","year":"2023"},{"key":"10.1016\/j.mam.2025.101423_bib201","series-title":"Regional Office for the Western Pacific","article-title":"Strategic framework for the comprehensive prevention and control of cervical cancer in the Western Pacific region 2023-2030 regional office for the Western Pacific","year":"2023"},{"key":"10.1016\/j.mam.2025.101423_bib202","series-title":"Target Product Profiles for Human Papillomavirus Screening Tests to Detect Cervical Pre-cancer and Cancer","year":"2024"},{"key":"10.1016\/j.mam.2025.101423_bib206","series-title":"Summary WHO SAGE Conclusions and Recommendations on Vaccine Hesitancy","year":"2015"},{"key":"10.1016\/j.mam.2025.101423_bib207","series-title":"Med. Image Learn. Ltd. Noisy Data - 1st Int. Workshop Milland 2022 Held Conjunction MICCAI 2022 Proc., Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)","first-page":"206","author":"Xue","year":"2022"},{"key":"10.1016\/j.mam.2025.101423_bib208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/09691413231184334","article-title":"Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: a data linkage analysis using the 45 and up study","volume":"31","author":"Yuill","year":"2024","journal-title":"J. Med. Screen"},{"key":"10.1016\/j.mam.2025.101423_bib209","article-title":"Prevalence of human papillomavirus and its prognostic value in vulvar cancer: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101423_bib210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clon.2014.10.006","article-title":"Need for radiotherapy in low and middle income countries \u2013 the silent crisis continues","volume":"27","author":"Zubizarreta","year":"2015","journal-title":"Clin. Oncol. R. Coll. Radiol. G. B."},{"key":"10.1016\/j.mam.2025.101423_bib211","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/0090-8258(81)90067-6","article-title":"Papillomavirus infections and human genital cancer","volume":"12","author":"zur Hausen","year":"1981","journal-title":"Gynecol. Oncol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:10:48Z","timestamp":1769033448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":205,"alternative-id":["S0098299725000871"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101423","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101423"}}